tk88 bet

Vietnam conditionally approves COVID-19 Vaccine Moderna

The Ministry of Health has granted conditional approval for COVID-19 Vaccine Moderna, manufactured by Spain’s Rovi Pharma Industrial Services, S.A and France’s Recipharm Monts, for emergency use in Vietnam.
Vietnam conditionally approves COVID-19 Vaccine Moderna ảnh 1Vietnam grants conditional approval for COVID-19 Vaccine Moderna. (Photo: AFP/VNA)
Hanoi (VNA) – The Ministry of Health has granted conditional approval forCOVID-19 Vaccine Moderna, manufactured by Spain’s Rovi Pharma IndustrialServices, S.A and France’s Recipharm Monts, for emergency use in Vietnam.

Underthe approval decision, the vaccine, also known as Spikevax, comes in doses of 0.5mlof mRNA molecules protected by lipid nanoparticles SM-102. It is supplied in acarton of 10 multiple-dose vials, with each vial containing 10 doses.

ZuelligPharma Vietnam Co. Ltd. is in charge of importing and distributing the vaccinein Vietnam. It must ensure safe delivery of Moderna vaccine in the country, andcooperate with Vietnamese authorities to check the quality of the vaccine beforeuse and instruct vaccination centres on how to store, distribute and administerthe vaccine.

Thisis the fifth vaccine conditionally authorised for emergency use by the Ministryof Health, following Oxford/AstraZeneca, Sputnik V, Sinopharm’s Vero-Cell andPfizer/BioNTech.

Thecountry aims to purchase around 150 million doses of COVID-19 vaccines to inoculateabout 70 percent of its population this year.

Closeto 3.5 million doses have been administered in the country as of June 28 morning.The number of fully vaccinated people totalled 172,944./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

☂ Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

▨ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|